RIGL20260918P35
RIGL Sep 18 2026 35.00 Put (RIGL260918P00035000)
option OPRA

rigel pharmaceuticals, inc., is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases.